‘This Company’ is showing a strong surge as Pfizer’s COVID-19 vaccine Phase 3 clinical trial nears completion! It is the first in Korea to develop the antibiotic intermediate ‘EDP-CI’ and has been exclusively supplying it to Pfizer in the US for a long time! Meanwhile, Pfizer is reportedly planning to request an emergency trial for the COVID-19 vaccine from the US FDA next month, and related stocks are expected to benefit!
“Buy and it falls, sell and it rises” ? this wasn’t just once or twice. It happened so often that I seriously considered quitting stocks. Desperate, I applied for a 3-day free trial, and my stock life changed 180 degrees. I regretted not applying sooner as my account returns were excellent. I am still very satisfied and using the VIP service.
(VIP Full-time Investor Kim Yong-su, 47 years old)
Now think of this as your last chance. If you miss this opportunity, you should quit.
It will explode exactly on “November 09”! Don’t miss out and regret it, buy at least 1 million KRW worth!
[AI Recent Limit-Up Hits]
*20.11.02 Syswork (269620) Limit-Up hit!
*20.10.30 Namseong (004270) Limit-Up hit!
*20.10.27 Phoenix Materials (050090) Limit-Up hit!
*20.10.23 ANP (015260) Limit-Up hit!
*20.10.21 Kyungin Electronics (009140) Limit-Up hit!
*20.10.19 KPX Life Science (114450) Limit-Up hit!
*20.10.16 Seohan (011370) Limit-Up hit!
*20.10.14 KMH Hightech (052900) Limit-Up hit!
*20.10.12 Access Bio (950130) Limit-Up hit!
*20.10.07 Camu ENC (013700) Limit-Up hit!
*20.10.05 Cellid (299660) Limit-Up hit!
▶▶ Only for 30 people. “Monday Limit-Up”! ▶Get it now◀
※First-come, first-served 30 people only! Both early and late rounds are over. The hero of the final injury time winning goal※
[Today’s Stocks of Interest]
#KPXLifeScience #VaxcellBio #JeilPharm #WooridulPharm #PeopleBio
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

